Faricimab HY-P99116 from MedChemExpress

Product Specs
ItemFaricimab
CompanyMedChemExpress
Price Supplier Page View Company Product Page
Catalog NumberHY-P99116
Research AreaMetabolic Disease
TypeInhibitor
Conjugate/TagUnconjugated

Add to Compare List

MedChemExpress

1 Deer Park Drive, Suite F

MONMOUTH JUNCTION, NJ 08852

United States

Phone: US Tel: 609-228-6898
US Fax: 609-228-5909
EU Tel: +4686500910

Email: sales@medchemexpress.com
eu.sales@MedChemExpress.com

Company Profile

Website: medchemexpress.com

(1) Targeting coupling of type H-like vessels and cell fate transition to delay soft tissue agingNature CommunicationsMay 6, 2026Zhuoning Miao, Ziyang Tong, Linjing Shi, Yang Fei, Tao Zhang, Chunmei Fan, Tian Qin, Jia Gao, Qiangqiang Zheng, Xianan Mo, et al.antibodies The CXCL12 protein (HY-P73661)、LIT927 (HY-112709)、CXCR7 antagonist (HY-139643) and Faricimab (HY-P99116) were obtained from MCE. ANG1 (Abcam, ab183701, 1:10000), ANG2 (Santa Cruz, sc-74403, 1:1000), VEGF-A

(2) Review of real-world evidence of dual inhibition of VEGF-A and ANG-2 with faricimab in NAMD and DMEInternational journal of retina and vitreousJanuary 17, 2024Penha FM, Masud M, Khanani ZA, Thomas M, Fong RD, Smith K, Chand A, Khan M, Gahn G, Melo GB, et al.

(3) Pharmaceutical compounding and storage of faricimab in a syringe for intravitreal injection do not impair stability and bi-specific binding propertiesInternational journal of retina and vitreousNovember 7, 2023Jørstad ØK, Foss S, Gjølberg TT, Mester S, Nyquist-Andersen M, Sivertsen MS, Fossum D, Gleditsch E, Moe MC, Andersen JT.

(4) Delineating effects of angiopoietin-2 inhibition on vascular permeability and inflammation in models of retinal neovascularization and ischemia/reperfusionFrontiers in cellular neuroscienceJanuary 1, 2023Canonica J, Foxton R, Garrido MG, Lin CM, Uhles S, Shanmugam S, Antonetti DA, Abcouwer SF, Westenskow PD.

(5) Faricimab: an investigational agent targeting the Tie-2/angiopoietin pathway and VEGF-A for the treatment of retinal diseasesExpert opinion on investigational drugsMarch 1, 2021Nicolò M, Ferro Desideri L, Vagge A, Traverso CE.

(6) Simultaneous Inhibition of Angiopoietin-2 and Vascular Endothelial Growth Factor-A with Faricimab in Diabetic Macular Edema: BOULEVARD Phase 2 Randomized TrialOphthalmologyAugust 1, 2019Sahni J, Patel SS, Dugel PU, Khanani AM, Jhaveri CD, Wykoff CC, Hershberger VS, Pauly-Evers M, Sadikhov S, Szczesny P, et al.

Be the First to Write a Review!

Faricimab from MedChemExpress

Description

MedChemExpress

Citations (6)

Reviews

Faricimab from MedChemExpress

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map